WHY IT MATTERS: If state health authorities move forward with potency restrictions or new labeling requirements, patients who rely on higher-concentration products for legitimate medical purposes may face reduced access or need to significantly adjust their dosing strategies. CLINICAL OVERVIEW: Public health officials are raising concerns about the increasing potency of cannabis products available in the legal market, particularly regarding exposure among adolescents and young people. The discussion centers on how THC concentrations in modern products differ substantially from those in cannabis consumed decades ago, and what that means for developing brains.
Modern Cannabis Is Hitting Gen Z Mental Health Hard – Neuroscience News
WHY IT MATTERS: Young people who use high-potency cannabis products frequently should understand that their risk for developing or worsening anxiety and depression is meaningfully elevated compared to non-users or infrequent users, and that risk increases the earlier in adolescence use begins. CLINICAL OVERVIEW: The relationship between high-potency cannabis and mental health conditions such as anxiety and depression is not incidental, and the shift toward products with dramatically elevated THC concentrations over recent decades has outpaced what most young developing brains can tolerate without consequence. Gen Z has grown up with near-unrestricted access to concentrates, vape cartridges, and edibles that bear little resemblance to the cannabis of prior generations, making direct comparisons across age cohorts scientifically problematic but still clinically instructive.